A Randomised Controlled Trial Assessing the Effects of Peri-operative Fenofibrate Administration on Abdominal Aortic Aneurysm Pathology: Outcomes From the FAME Trial.

CONCLUSION: A short course of 145 mg of fenofibrate/day did not lower concentrations of OPN or aortic macrophage density in people with large AAAs. PMID: 32703634 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32703634?dopt=Abstract

Source: PubMed: Eur J Vasc Endovasc ... - July 19, 2020 Category: Surgery Authors: Moxon JV, Rowbotham SE, Pinchbeck JL, Lazzaroni SM, Morton SK, Moran CS, Quigley F, Jenkins JS, Reid CM, Cavaye D, Jaeggi R, Golledge J Tags: Eur J Vasc Endovasc Surg Source Type: research